Axalta amends AkzoNobel merger agreement to revise post-merger governance terms
On July 23, 2026, Axalta entered Amendment No. 2 to its merger agreement with AkzoNobel, changing governance terms for the combined company. The amendment sets annual re-election of all MergeCo directors after an initial three-year period and a two-thirds non-executive director approval threshold for specified matters during that period. The companies said the changes leave the August 5, 2026 AkzoNobel EGM and Axalta SGM on schedule, so shareholder votes are not affected by the amendment.
Key points
- Annual re-election of all MergeCo directors after the initial three-year period; the press release says this was previously contemplated after five years.
- Two-thirds non-executive director approval threshold during the initial three years for director appointments and dismissals, CEO, Deputy CEO and CFO changes, Chair and Vice Chair titles, and remuneration policy amendments; the press releas
- AkzoNobel EGM and Axalta SGM planned for August 5, 2026 are proceeding with existing agenda items unaffected.
The filing
Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 23, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.